Half-year report · HY
7071.TEDINET S100Y3ZE
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥25.6bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥49.2bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥2.8bn | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥3.7bn | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.3bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.8bn | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.8bn | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.8bn | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.7bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.7bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.9bn | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥2.7bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥83.9bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥83.9bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥82.7bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥46.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥47.8bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥37.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥36.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥35.2bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.2bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.8bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.0bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.3bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.2bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.4bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.9bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.2bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.4bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.5bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥19.41 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.52 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.55 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥19.41 | 2025-10-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.51 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.55 | 2024-10-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 45.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 23
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | ¥0 |
| Comprehensive Medical Supportreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥569m |
| Comprehensive Medical Supportreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥567m |
| Comprehensive Medical Supportreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥2m |
| Comprehensive Medical Supportreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥324m |
| Ishinkanreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥25.0bn |
| Ishinkanreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥25.0bn |
| Ishinkanreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥2.5bn |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥25.6bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥25.6bn |
| —segment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥2m |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥2.8bn |
| Comprehensive Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥228m |
| Comprehensive Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥228m |
| Comprehensive Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥68m |
| Ishinkanreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥23.6bn |
| Ishinkanreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥23.6bn |
| Ishinkanreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥3.7bn |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥23.8bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥23.8bn |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥3.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 480
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E35140-000ComprehensiveMedicalSupportReportableSegmentMember | 567000000 | JPY |
| Revenues from external customers | InterimDuration_ReportableSegmentsMember | 25600000000 | JPY |
| Revenues from external customers | InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | InterimDuration | 25600000000 | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E35140-000IshinkanReportableSegmentMember | － | JPY |
| Transactions with other segments | InterimDuration_jpcrp040300-ssr_E35140-000ComprehensiveMedicalSupportReportableSegmentMember | 2000000 | JPY |
| Transactions with other segments | InterimDuration_ReportableSegmentsMember | 2000000 | JPY |
| Transactions with other segments | InterimDuration_ReconcilingItemsMember | -2000000 | JPY |
| Transactions with other segments | InterimDuration | － | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E35140-000IshinkanReportableSegmentMember | 25033000000 | JPY |
| Net sales | InterimDuration_jpcrp040300-ssr_E35140-000ComprehensiveMedicalSupportReportableSegmentMember | 569000000 | JPY |
| Net sales | InterimDuration_ReportableSegmentsMember | 25603000000 | JPY |
| Net sales | InterimDuration_ReconcilingItemsMember | -2000000 | JPY |
| Net sales | InterimDuration | 25600000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E35140-000IshinkanReportableSegmentMember | 2479000000 | JPY |
| Operating income | InterimDuration_jpcrp040300-ssr_E35140-000ComprehensiveMedicalSupportReportableSegmentMember | 324000000 | JPY |
| Operating income | InterimDuration_ReportableSegmentsMember | 2804000000 | JPY |
| Operating income | InterimDuration_ReconcilingItemsMember | -0 | JPY |
| Operating income | InterimDuration | 2804000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の５第１項の表の第１号 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2026-05-14 | |
| Semi annual accounting period cover page | FilingDateInstant | Original text (Japanese)第10期中(自 2025年10月１日 至 2026年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社アンビスホールディングス | |
| Company name in english cover page | FilingDateInstant | Amvis Holdings, Inc. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役 CEO 柴原 慶一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都中央区京橋一丁目６番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)03-6262-5105（代表） | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役 山口 真吾 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区京橋一丁目６番１号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)03-6262-5105（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 山口 真吾 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E35140 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 70710 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社アンビスホールディングス | |
| Filer name in english | FilingDateInstant | Amvis Holdings, Inc. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2025-10-01 | |
| Current period end date | FilingDateInstant | 2026-03-31 | |
| Type of current period | FilingDateInstant | HY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |